Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
21 studies found for:    Open Studies | "Rosacea"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Rosacea"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Photodynamic Therapy for Papulopustular Rosacea
Conditions: Rosacea;   Papulopustular Rosacea
Interventions: Drug: Aminolevulinic acid topical solution 20%;   Device: Blu-U Light Therapy;   Other: Placebo vehicle only
2 Recruiting Timolol for the Treatment of Acne and Rosacea
Conditions: Acne Vulgaris;   Rosacea
Intervention: Drug: Timolol
3 Unknown  An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated Erythema
Condition: Papulopustular Rosacea
Interventions: Drug: Cromolyn Sodium;   Drug: Normal Saline
4 Recruiting Genetic Basis of Rosacea
Condition: Rosacea
Intervention: Genetic: buccal swab
5 Recruiting Genetic Basis of Rosacea Study (Control)
Condition: Rosacea
Intervention: Genetic: Skin Biopsy
6 Recruiting Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients
Condition: Rosacea
Interventions: Other: Obtaining a blood sample;   Device: Reflectance confocal microscopy;   Device: Sebumeter;   Device: Video dermoscopy
7 Unknown  RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea
Condition: Rosacea
Interventions: Device: Radiofrequence;   Drug: Doxycycline
8 Recruiting Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With Rosacea
Condition: Rosacea
Interventions: Other: internet survey;   Drug: brimonidine topical gel 0.33%
9 Not yet recruiting Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
Condition: Rosacea
Intervention: Drug: Ivermectin
10 Recruiting Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
Condition: Rosacea
Interventions: Drug: Ivermectin;   Drug: Ivermectin (reference);   Drug: Placebo
11 Not yet recruiting Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face
Condition: Rosacea
Interventions: Drug: Azelaic acid foam;   Drug: Azelaic acid foam - Placebo
12 Recruiting Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
Condition: Rosacea
Intervention: Drug: Omiganan
13 Recruiting Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
Condition: Rosacea
Interventions: Drug: Omiganan;   Drug: Vehicle
14 Recruiting Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
Condition: Rosacea
Interventions: Drug: Omiganan;   Drug: Vehicle
15 Recruiting Clinical Endpoint Study of Ivermectin 1% Cream
Condition: Moderate to Severe Papulopustular Rosacea
Interventions: Drug: Ivermectin Cream, 1%;   Drug: Placebo/Vehicle cream
16 Recruiting Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis
Conditions: Demodicidosis;   Rosacea
Intervention: Drug: ivermectin cream 0.5%
17 Recruiting Potential Research Study Participant Registry
Conditions: Acne;   Actinic Keratosis;   Dysplastic Nevi;   Eczema;   Psoriasis;   Skin Cancer;   Rosacea;   Leg Ulcers;   Foot Ulcers;   Atopic Dermatitis
Intervention:
18 Recruiting A Study to Assess the Efficacy, Safety and Tolerability of DFD-04
Condition: Rosacea
Interventions: Drug: DFD-04 Ointment;   Other: Placebo Ointment
19 Recruiting Inflammatory Cells From Various Pathologies
Conditions: Atopic Dermatitis;   Acne Rosacea;   Acne Vulgaris
Intervention:
20 Not yet recruiting Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea
Condition: Meibomian Gland Dysfunction
Intervention: Procedure: meibomian gland probing

   Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results    Last Page
Indicates status has not been verified in more than two years